MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Self-perception of Health and Depressive Symptomatology in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.

    S. Ospina-Otalvaro, C A. Hurtado-Gonzalez, J F. Ayala-Rico, J M. Márquez, M I. Ortiz Agudelo, C O. Moreno, K. Rivera, F. Rojas, S. Guerrero (Cali, Colombia)

    Objective: To identify whether depressive symptomatology correlates with self-perception of health in patients with IPDWD. Background: Parkinson's disease is a neurodegenerative pathology characterized by motor…
  • 2024 International Congress

    Role of Wearable Devices in a Physical Activity Coaching Program for People with Parkinson Disease

    A. Pacheco, K. Long, D. Wani, J. Alomar, D. Kipnis, C. Macpherson (NYC, USA)

    Objective: Use a mixed-methods approach to evaluate wear-time and physical activity (PA) levels, and explore individual perspectives and feature preferences of people with Parkinson Disease…
  • 2024 International Congress

    ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment

    R. Scherbaum, E. Hinrichs, A. Horstmann, J. Schmidt-Fleischer, J. Stein, J. Geritz, J. Welzel, E. Kwon, J. Oppermann, V. Tschentscher, A. Mattukat, S. Muhlack, S. Faissner, C. Hansen, K. Winklhofer, R. Gold, W. Maetzler, N. Timmesfeld, L. Tönges (Bochum, Germany)

    Objective: To describe (1) the real-world effectiveness of the multidisciplinary inpatient rehabilitation (MIR) ‘Parkinson’s Disease Multimodal Complex Treatment’ (PD-MCT) in people with PD (PwP) compared…
  • 2024 International Congress

    Parkinson’s Disease Clinical Subtypes Differ in Health-Related QOL

    E. Carr, T. Cash, C. Lessov-Schlaggar, H. Hwang, A. Eid, P. Kotzbauer, J. Perlmutter, M. Campbell (St. Louis, USA)

    Objective: To determine whether clinical subtypes of Parkinson disease (PD) differ in health-related quality of life (QOL). Background: Health-related QOL varies for individuals with PD.…
  • 2024 International Congress

    Health Care Utilization at the End-Of-Life in Parkinson´s Disease

    B. Leavy, E. åkesson, J. Lökk, T. Schultz, P. Strang, E. Franzén (Stockholm, Sweden)

    Objective: This study aims to increase knowledge concerning end of life health care utilization among an urban-dwelling Parkinson's disease (PD) cohort. More specifically we investigated frequency…
  • 2024 International Congress

    Nocturnal Use of Add-On Medications for Parkinson’s Disease: Post Hoc Analysis of the COSMOS Study

    T. Gurevich, S. O'Sullivan, J. Parra, M. O'Meara, J. Zamudio, A. Fasano (Tel Aviv-Yafo, Israel)

    Objective: To assess nighttime use of add-on medications for Parkinson’s disease (PD) in a post hoc analysis of the COSMOS (COmedication Study assessing Mono- and…
  • 2024 International Congress

    Effect of Istradefylline on Motor and Non-motor Symptoms in Patients with Parkinson’s Disease: the ISTRA ADJUST PD Randomized, Controlled Study

    H. Nagayama, T. Hatano, R. Sengoku, N. Yanagisawa, O. Kano (Tokyo, Japan)

    Objective: To examine the effects of istradefylline on motor and non-motor symptoms in Parkinson’s disease (PD) patients with wearing-off phenomena. Background: Previous results [1,2] of…
  • 2024 International Congress

    Impact of IPX203 on Parkinson’s patients’ motor states upon awakening: analysis of patient diary data

    S. Isaacson, H. Fernandez, C. Kilbane, G. Banisadr, A. Pitman, S. Fisher, R. D'Souza (Boca Raton, USA)

    Objective: To evaluate “On” upon awakening in Parkinson’s disease patients taking IPX203 in the RISE-PD phase 3 clinical trial. Background: IPX203 is a novel extended-release,…
  • 2024 International Congress

    Long-term Safety and Efficacy for Motor Fluctuations and Quality of Life With Foslevodopa/Foscarbidopa in Patients With Advanced Parkinson’s Disease: Interim Results From an Ongoing Open Label Extension

    F. Bergquist, J. Aldred, C. Carroll, E. Danielsen, M. Facheris, R. Gupta, A. Jeong, A. Spiegel, V. Fung (Mölndal, Sweden)

    Objective: Evaluate long-term motor symptom control and improvement in quality of life (QoL) with foslevodopa/foscarbidopa (LDp/CDp) compared with baseline (BL) values from the parent study…
  • 2024 International Congress

    Parkinson’s Progression Markers Initiative (PPMI): Investigating Biomarker Driven PD Progression

    B. Mcmahon, A. Siderowf, T. Simuni, C. Tanner, B. Mollenhauer, C. Coffey, D. Galasko, K. Poston, L. Chahine, R. Dobkin, T. Foroud, K. Kieburtz, D. Weintraub, K. Merchant, M. Frasier, T. Sherer, S. Chowdury, E. Brown, R. Alcalay, A. Videnovic, K. Fabrizio, E. Flagg, C. Stanley, K. Marek (Baltimore, USA)

    Objective: PPMI is a longitudinal, observational study enrolling PD participants, individuals at risk for PD, and healthy controls (HCs). The study investigates clinical, imaging, genetic…
  • « Previous Page
  • 1
  • …
  • 178
  • 179
  • 180
  • 181
  • 182
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #29509 (not found)
  • Expanding the Phenotype of KCNA2 Mutation: Tics and Stereotypies
  • #22661 (not found)
  • #29591 (not found)
  • Movement disorders in chronic obstructive pulmonary disease (COPD); the effect of pulmonary disease to brain
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley